QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Aligned, Energised – From Reflection to Direction for 2026
This Wednesday, we gathered in Stockholm for the Quantify Research 2026 Kick-Off.
Colleagues joined from Finland, Norway and Denmark, with our India team participating online.
We reflected on a strong 2025.
Then we set clear priorities for the year ahead.
Our focus remains clear with our ABCs:
🟢 A — AI as a tool
Developed and applied pragmatically to increase efficiency and enhance the quality of client delivery.
📊 B — Business Development
A collective responsibility, spanning […]
Sweden: A data goldmine – Linked, reliable, research-ready 📊
Sweden’s RWD ecosystem is one of the most powerful globally — rich in coverage, high in trust, and fully linkable across registers via the personal identity number unique to every resident.
Thousands of peer-reviewed publications demonstrate its value.
With >100 disease-specific registries, laboratory data, national databases, and healthcare records, Sweden supports rigorous, longitudinal studies across disease areas, clinical outcomes, and health economics.
Regulatory-grade evidence-globally […]
Welcome Petri!
👋New colleague in HEOR & Market Access
This week, we’re pleased to welcome Petri Niinisalo, PhD to Quantify!
He joins our MAS team in Helsinki, bringing deep expertise in:
◾ Health economic modelling
◾ Price & reimbursement in Finland and beyond
Petri holds a PhD in pharmaceutical research (University of Turku) and is completing a master’s in health economics (University of Eastern Finland).
He joins us from roles […]
Quantify Research at the 6th Nordic RWE & AI Conference
Come meet our Quantify Research team: ready to talk real-world data, access, and the role of AI in smarter drug development.
From the mainstage to breakout sessions, we’re joining this year’s 6th Nordic RWE & AI Conference (Jan 27–28) | University of Helsinki, Main Auditorium and Agora Hall to explore a central […]